https://www.biospace.com/press-releases/rhythm-pharmaceuticals-to-announce-topline-results-from-phase-2-trial-evaluating-oral-mc4r-agonist-bivamelagon-in-acquired-hypothalamic-obesity
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist...
https://www.endocrine.org/journals/journal-of-the-endocrine-society/cardiometabolic-risk-markers-in-children-with-obesity
Cardiometabolic Risk Markers in Children With Obesity and Variants in MC4R Pathway-Related Genes |...
We compared the severity of obesity and cardiometabolic risk markers in children with MC4R pathway-related clinically reported genetic variants relative to...
https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-estadisticas-el-polimorfismo-rs483145-del-gen-S2530016421001567
MC4R
mc4r
https://www.path4hcps.com/
Home | The platform for Rare MC4R pathway diseases: Diagnosis and Management
the platformrare
https://www.sri.com/publication/association-of-the-rs17782313-rs17773430-and-rs34114122-polymorphisms-of-near-mc4r-gene-with-obesity-related-biomarkers-in-a-spanish-pediatric-cohort/
Association of the rs17782313, rs17773430 and rs34114122 Polymorphisms of/near MC4R Gene with...
Jul 27, 2023 - Our results highlight that metabolic risk factors, especially alterations in carbohydrate metabolism, were related to rs17782313.
of the
https://dergipark.org.tr/en/pub/cumj/article/1447513
The relationship of energy-restricted diet with FTO and MC4R gene polymorphism in patients with...
Sep 30, 2024 - Cukurova Medical Journal | Volume: 49 Issue: 3
https://www.elsevier.es/en-revista-endocrinologia-diabetes-nutricion-english-ed--413-articulo-the-rs483145-polymorphism-mc4r-gene-S253001802200066X
The rs483145 polymorphism of MC4R gene is not associated with obesity in the Chilean population:...
IntroductionThe melanocortin receptor 4 (MC4R) participates in the control of appetite at
https://mc4r.org.uk/
Melanocortin 4 Receptor | Welcome to the MC4R Gene Website
melanocortin 4 receptorwelcomemc4rgene
https://www.biospace.com/press-releases/palatin-reports-positive-appetite-suppression-results-from-phase-2-obesity-study-of-mc4r-agonist-bremelanotide-and-tirzepatide
Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist...